Association of preoperative chronic opioid use with 1-year revision rate, mortality, and patient-reported outcomes after primary hip and knee arthroplasty: age, sex and BMI matter – a Dutch register-based study
DOI:
https://doi.org/10.2340/17453674.2025.44597Keywords:
Arthroplasty, Hip, Knee, Opioids, Osteoarthrosis, OutcomesAbstract
Background and purpose: Our aim was to study the association between chronic preoperative opioid use and 1-year revision rate, mortality, and patient-reported outcomes (PROs) after primary total knee and hip arthroplasty (TKA/THA). We also investigated whether age, sex, or BMI modified these associations.
Methods: TKAs and THAs performed for osteoarthritis between 2013 and 2018, originating from the Dutch Arthroplasty Register, were linked to the Dutch Foundation for Pharmaceutical Statistics. Chronic preoperative opioid use was defined as > 1,800 morphine mg equivalent dispensed 1 year before surgery and ≥ 1 opioid prescribed 30 days before surgery. Outcomes were 1-year revision rate, mortality, self-reported physical functioning, pain, and quality of life (QoL). Incidence rates were calculated; Cox regression and linear mixed models were used. We assessed effect modification by assessment of supra-additive effects.
Results: Preoperative chronic opioid use occurred in 4.5% of 29,739 THAs and 3.4% of 27,873 TKAs. Chronic opioid use doubled mortality and revision rates for both TKAs and THAs (range of hazard ratios 1.7–2.1). The association of preoperative opioid use with 1-year revision rate was larger in males, in patients with a BMI ≤ 30 (THA) and > 30 (TKA), and 66–75-year-olds. Younger patients exhibited a more pronounced association between opioid use and reduced physical functioning and QoL, and increased pain. Sex and BMI had no modifying effects on PROs.
Conclusion: Preoperative chronic opioid use was associated with a higher likelihood of 1-year revision and mortality and worse PROs. The associations with revision risk were modified by age, sex, and BMI. Age also had a modifying effect on PROs.
Downloads
References
Jin Y, Solomon D H, Franklin P D, Lee Y C, Lii J, Katz J N, et al. Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees. Osteoarthritis Cartilage 2019; 27(10): 1445-53. doi: 10.1016/j.joca.2019.05.023. DOI: https://doi.org/10.1016/j.joca.2019.05.023
van Brug H E, Nelissen R G H H, Rosendaal F R, van Dorp E L A, Bouvy M L, Dahan A, et al. What changes have occurred in opioid prescriptions and the prescribers of opioids before TKA and THA? A large national registry study. Clin Orthop Relat Res 2023; 481(9): 1729-31. doi: 10.1097/corr.0000000000002653. DOI: https://doi.org/10.1097/CORR.0000000000002733
Welsch P, Petzke F, Klose P, Häuser W. Opioids for chronic osteoarthritis pain: an updated systematic review and meta–analysis of efficacy, tolerability and safety in randomized placebo–controlled studies of at least 4 weeks double–blind duration. Eur J Pain (London, England) 2020; 24(4): 685-703. doi: 10.1002/ejp.1522. DOI: https://doi.org/10.1002/ejp.1522
Bannuru R R, Osani M C, Vaysbrot E E, Arden N K, Bennell K, Bierma-Zeinstra S M A, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 27(11): 1578-89. doi: 10.1016/j.joca.2019.06.011. DOI: https://doi.org/10.1016/j.joca.2019.06.011
Hagen K B, Smedslund G, Østerås N, Jamtvedt G. Quality of community-based osteoarthritis care: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2016; 68(10): 1443-52. doi: 10.1002/acr.22891. DOI: https://doi.org/10.1002/acr.22891
Malahias M A, Loucas R, Loucas M, Denti M, Sculco P K, Greenberg A. Preoperative opioid use is associated with higher revision rates in total joint arthroplasty: a systematic review. J Arthroplasty 2021; 36(11): 3814-21. doi: 10.1016/j.arth.2021.06.017.
Chen L, Wang Q, Li D, Chen C, Li Q, Kang P. Meta-analysis of retrospective studies suggests that the pre-operative opioid use is associated with an increased risk of adverse outcomes in total hip and or knee arthroplasty. Int Orthop 2021; 45(8): 1923-32. doi: 10.1007/s00264-021-04968-9. DOI: https://doi.org/10.1007/s00264-021-04968-9
Goplen C M, Verbeek W, Kang S H, Jones C A, Voaklander D C, Churchill T A, et al. Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord 2019; 20(1): 234. doi: 10.1186/s12891-019-2619-8. DOI: https://doi.org/10.1186/s12891-019-2619-8
Terhune E B, Hannon C P, Burnett R A, Della Valle C J. Preoperative opioids and the dose-dependent effect on outcomes after total hip arthroplasty. J Arthroplasty 2022; 37(8s): S864-s70. doi: 10.1016/j.arth.2021.12.017. DOI: https://doi.org/10.1016/j.arth.2021.12.017
Kim S C, Jin Y, Lee Y C, Lii J, Franklin P D, Solomon D H, et al. Association of preoperative opioid use with mortality and short-term safety outcomes after total knee replacement. JAMA Netw Open 2019; 2(7): e198061. doi: 10.1001/jamanetworkopen.2019.8061. DOI: https://doi.org/10.1001/jamanetworkopen.2019.8061
Sayed-Noor A S, Mukka S, Mohaddes M, Kärrholm J, Rolfson O. Body mass index is associated with risk of reoperation and revision after primary total hip arthroplasty: a study of the Swedish Hip Arthroplasty Register including 83,146 patients. Acta Orthop 2019; 90(3): 220-5. doi: 10.1080/17453674.2019.1594015. DOI: https://doi.org/10.1080/17453674.2019.1594015
Peters R M, Van Steenbergen L N, Stewart R E, Stevens M, Rijk P C, Bulstra S K, et al. Patient Characteristics influence revision rate of total hip arthroplasty: American Society of Anesthesiologists score and body mass index were the strongest predictors for short-term revision after primary total hip arthroplasty. J Arthroplasty 2020; 35(1): 188-92.e2. doi: 10.1016/j.arth.2019.08.024. DOI: https://doi.org/10.1016/j.arth.2019.08.024
Gademan M G J, Van Steenbergen L N, Cannegieter S C, Nelissen R, Marang-Van de Mheen P J. Population-based 10-year cumulative revision risks after hip and knee arthroplasty for osteoarthritis to inform patients in clinical practice: a competing risk analysis from the Dutch Arthroplasty Register. Acta Orthop 2021; 92(3): 280-4. doi: 10.1080/17453674.2021.1876998. DOI: https://doi.org/10.1080/17453674.2021.1876998
Hofstede S N, Gademan M G J, Stijnen T, Nelissen R, Marang-van de Mheen P J. The influence of preoperative determinants on quality of life, functioning and pain after total knee and hip replacement: a pooled analysis of Dutch cohorts. BMC Musculoskelet Disord 2018; 19(1): 68. doi: 10.1186/s12891-018-1991-0. DOI: https://doi.org/10.1186/s12891-018-1991-0
Mukka S, Rolfson O, Mohaddes M, Sayed-Noor A. The effect of body mass index class on patient-reported health-related quality of life before and after total hip arthroplasty for osteoarthritis: registry-based cohort study of 64,055 patients. JB JS Open Access 2020; 5(4): e20.00100. doi: 10.2106/jbjs.Oa.20.00100. DOI: https://doi.org/10.2106/JBJS.OA.20.00100
Bedene A, Lijfering W M, Niesters M, Van Velzen M, Rosendaal F R, Bouvy M L, et al. Opioid prescription patterns and risk factors associated with opioid use in the Netherlands. JAMA Netw Open 2019; 2(8): e1910223. doi: 10.1001/jamanetworkopen.2019.10223. DOI: https://doi.org/10.1001/jamanetworkopen.2019.10223
Dutch Arthroplasty Register. Online LROI annual report 2022. ‘s Hertogenbosch: LROI; 2022. Available from: https://www.lroi-report.nl/
Griens A M G F, Kroon J D L, Lukaart J S, Postma D J. SFK Data en feiten 2019. Den Haag: Stichting Farmaceutische Kengetallen; 2019 [cited 2021 March 23]. Available from: https://www.sfk.nl/publicaties/data-en-feiten/data-en-feiten-2019
Van Brug H E, Rosendaal F R, Van Steenbergen L N, Nelissen R G H H, Gademan M G J. Data linkage of two national databases: lessons learned from linking the Dutch Arthroplasty Register with the Dutch Foundation for Pharmaceutical Statistics. PLoS One 2023; 18(3): e0282519. doi: 10.1371/journal.pone.0282519. DOI: https://doi.org/10.1371/journal.pone.0282519
Opioid Morphine Milligram Equivalent conversion factors: Centers for Medicare & Medicaid Service; 2014. Available from: https://afsra.org/pdf/Downloads/Opioid-Morphine-EQ-Conversion-Factors-March-2015.pdf
de Oliveira Costa J, Bruno C, Baranwal N, Gisev N, Dobbins T A, Degenhardt L, et al. Variations in long-term opioid therapy definitions: a systematic review of observational studies using routinely collected data (2000–2019). Br J Clin Pharmacol 2021; 87(10): 3706-20. doi: 10.1111/bcp.14798. DOI: https://doi.org/10.1111/bcp.14798
Lamers L M, McDonnell J, Stalmeier P F, Krabbe P F, Busschbach J J. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006; 15(10): 1121-32. doi: 10.1002/hec.1124. DOI: https://doi.org/10.1002/hec.1124
Knol M J, VanderWeele T J, Groenwold R H, Klungel O H, Rovers M M, Grobbee D E. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26(6): 433-8. doi: 10.1007/s10654-011-9554-9. DOI: https://doi.org/10.1007/s10654-011-9554-9
Corraini P, Olsen M, Pedersen L, Dekkers O M, Vandenbroucke J P. Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators. Clin Epidemiol 2017; 9331-8. doi: 10.2147/clep.S129728. DOI: https://doi.org/10.2147/CLEP.S129728
Malahias M-A, Loucas R, Loucas M, Denti M, Sculco P K, Greenberg A. Preoperative opioid use is associated with higher revision rates in total joint arthroplasty: a systematic review. J Arthroplasty 2021; 36(11): 3814-21. doi: 10.1016/j.arth.2021.06.017. DOI: https://doi.org/10.1016/j.arth.2021.06.017
Roerink A M C, Nelissen R, Holder C, Graves S E, Dunbar M, Bohm E, et al. Sex-based differences in risk of revision for infection after hip, knee, shoulder, and ankle arthroplasty in osteoarthritis patients: a multinational registry study of 4,800,000 implants. Acta Orthop 2024; 95730-6. doi: 10.2340/17453674.2024.42183. DOI: https://doi.org/10.2340/17453674.2024.42183
Goesling J, Moser S E, Zaidi B, Hassett A L, Hilliard P, Hallstrom B, et al. Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain 2016; 157(6): 1259-65. doi: 10.1097/j.pain.0000000000000516. DOI: https://doi.org/10.1097/j.pain.0000000000000516
Zhang B, Rao S, Mekkawy K L, Rahman R, Sarfraz A, Hollifield L, et al. Risk factors for pain after total hip arthroplasty: a systematic review. Arthroplasty 2023; 5(1): 19. doi: 10.1186/s42836-023-00172-9. DOI: https://doi.org/10.1186/s42836-023-00172-9
Klenø A S, Mechlenburg I, Gademan M G J, Sørensen H T, Pedersen A B. Do sex, age, and comorbidities modify the association of socioeconomic status and opioid use after total hip arthroplasty?: a population-based study from the Danish Hip Arthroplasty Register. Acta Orthop 2024; 95233-42. doi: 10.2340/17453674.2024.40708. DOI: https://doi.org/10.2340/17453674.2024.40708
Weick J, Bawa H, Dirschl D R, Luu H H. Preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty. J Bone Joint Surg Am 2018; 100(14): 1171-6. doi: 10.2106/JBJS.17.01414. DOI: https://doi.org/10.2106/JBJS.17.01414
Bloom D A, Manjunath A K, Gualtieri A P, Fried J W, Schwarzkopf R M, Macaulay W B, et al. Patient satisfaction after total hip arthroplasty is not influenced by reductions in opioid prescribing. J Arthroplasty 2021; 36(7s): S250-s7. doi: 10.1016/j.arth.2021.02.009. DOI: https://doi.org/10.1016/j.arth.2021.02.009
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Heather E van Brug, Rob G H H Nelissen, Frits R Rosendaal, Liza N van Steenbergen, Marcel L Bouvy, Albert Dahan, Maaike Gademan
This work is licensed under a Creative Commons Attribution 4.0 International License.
